// App-Quantinova.ai

OP0211 : A PRELIMINARY INVESTIGATION OF TREAT-TO-TARGET CRITERIA USING BSAS, RAPID3 AND PHYSICIAN GLOBAL IN BEHCE-S SYNDROME

Researchers

Presenter

  • Y. Yazici

Principal Investigators

  • Y. Bata

  • C. J. Swearingen

Medical Centers

  • Rheumatology, HSS, New York, NY

  • Biostatistics, University of Arkansas, Little Rock, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Behcet disease

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Mycophenolic acid

  • Oraprine

  • Cyclosporine eent

  • Methotrexate

  • Colchicine

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved